Mumbai, April 18 -- Divis Laboratories has signed a long term manufacturing and supply agreement with a global pharma company. Under the agreement, the company will manufacture and supply advance intermediates as per the commercial terms agreed between the parties. The company is planning to increase its manufacturing capacity with an estimated investment of Rs 650-700 crore to be funded from internal accruals.

Published by HT Digital Content Services with permission from Capital Market....